8C5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Coherus BioSciences Inc

Watchlist Manager

Watchlist

Price: 1.673 EUR 12.89%

Market Cap: €186.3m

C	Coherus BioSciences Inc SWB:8C5	US
	GomSpace Group AB F:1G2	SE
T	TotalEnergies SE SWB:TOTB	FR
M	Mercer International Inc F:AEZ	CA
K	Kroger Co XMUN:KOG	US
	Strongpoint ASA F:PGT	NO
T	Trillion Energy International Inc OTC:TRLEF	CA
	DSM-Firmenich AG F:ZX61	CH
I	Impala Platinum Holdings Ltd XBER:IPHB	ZA
M	MakeMyTrip Ltd F:MY1	IN
C	China Mobile Ltd XBER:CTM	CN
L	London Stock Exchange Group PLC XMUN:LS4C	UK
O	Oji Holdings Corp DUS:OJI	JP
B	Brixmor Property Group Inc F:BXR	US
	Ionis Pharmaceuticals Inc NASDAQ:IONS	US
	Tesmec SpA F:2GV	IT

Profitability Summary

Coherus BioSciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

52%

Gross Margin is Increasing

58% > 67%

Negative Operating Margin

-410%

Negative 3Y Average Operating Margin

-173%

Declining Operating Margin

-130% > -410%

Exceptional Net Margin

398%

Strong 3Y Average Net Margin

35%

Net Margin is Increasing

-148% > 398%

Negative Free Cash Flow Margin

-328%

Negative 3Y Average Free Cash Flow Margin

-91%

Declining Free Cash Flow Margin

-140% > -328%

Negative ROE

-473%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-52%

ROIC is Increasing

-96% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.